Kaiser Peter
SEC CIK 2011869 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| OCUL | OCULAR THERAPEUTIX, INC | Chief Development Off | 264.4K | — | $327.2K | 11 | 2024-10-02 | 2026-08-24 |
Most active insiders at OCUL, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Dugel Pravin | See Remarks, Dir | — | $1.94M |
| 2 | LINDSTROM RICHARD L MD | Dir | $461.4K | — |
| 3 | Saroj Namrata | Chief Business Off | — | $277.8K |
| 4 | Heier Jeffrey S. | CSO | — | $243.3K |
| 5 | Kaiser Peter | Chief Development Off | — | $222.9K |
| 6 | Waheed Nadia | Chief Medical Off | — | $220.9K |
| 7 | Notman Donald | See Remarks | — | $216.1K |
| 8 | Nayak Sanjay | Chief Strategy Off | — | $166.4K |
| 9 | Anderman Todd | CLO | — | $137.4K |
| 10 | Robinson David Wayne | Gbl CCO | — | — |
Transactions 11
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-08-26 17:59 | 2026-08-24 | OCUL | OCULAR THERAPEUTIX, INC | Kaiser Peter | Chief Development Off | S - Sale | $10.77 | -3,035 | 264.4K | -1% | -$32.7K |
| T | 2026-05-28 16:07 | 2026-05-26 | OCUL | OCULAR THERAPEUTIX, INC | Kaiser Peter | Chief Development Off | S - Sale | $8.20 | -2,967 | 266.1K | -1% | -$24.3K |
| 2026-02-25 | 2026-02-23 | OCUL | OCULAR THERAPEUTIX, INC | Kaiser Peter | Chief Development Off | S - Sale | $8.28 | -2,810 | 269.1K | -1% | -$23.3K | |
| D | 2026-01-06 | 2026-01-02 | OCUL | OCULAR THERAPEUTIX, INC | Kaiser Peter | Chief Development Off | A - Grant | $0.00 | +79.1K | 271.9K | +41% | $0 |
| 2025-11-26 | 2025-11-24 | OCUL | OCULAR THERAPEUTIX, INC | Kaiser Peter | Chief Development Off | S - Sale | $12.02 | -3,007 | 191.4K | -2% | -$36.1K | |
| 2025-10-06 | 2025-10-02 | OCUL | OCULAR THERAPEUTIX, INC | Kaiser Peter | Chief Development Off | S - Sale | $11.03 | -9,653 | 194.4K | -5% | -$106.5K | |
| 2025-08-27 | 2025-08-25 | OCUL | OCULAR THERAPEUTIX, INC | Kaiser Peter | Chief Development Off | S - Sale | $12.04 | -3,011 | 204.1K | -1% | -$36.3K | |
| 2025-05-27 | 2025-05-23 | OCUL | OCULAR THERAPEUTIX, INC | Kaiser Peter | Chief Development Off | S - Sale | $7.17 | -2,974 | 207.1K | -1% | -$21.3K | |
| 2025-02-26 | 2025-02-24 | OCUL | OCULAR THERAPEUTIX, INC | Kaiser Peter | Chief Development Off | S - Sale | $6.87 | -3,009 | 210.1K | -1% | -$20.7K | |
| 2024-11-27 | 2024-11-25 | OCUL | OCULAR THERAPEUTIX, INC | Kaiser Peter | Chief Development Off | S - Sale | $9.01 | -2,897 | 213.1K | -1% | -$26.1K | |
| D | 2024-10-04 | 2024-10-02 | OCUL | OCULAR THERAPEUTIX, INC | Kaiser Peter | Chief Development Off | A - Grant | $0.00 | +100.0K | 216.0K | +86% | $0 |
Purchase Sale Sale after option exercise All abbreviations